Using a spontaneous model of metastatic melanoma and clinical samples, HPK1 is dysregulated in peripheral NK cells during metastasis and causally linked to NK cell dysfunction, metastatic progression, and response to immune checkpoint therapy via limiting NK cell cytotoxicity and expansion. This evidence concerns the gene MAP4K1 and metastatic melanoma.